- Home
- MNTK vs EYPT Comparison
MNTK vs EYPT Comparison
Compare MNTK & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTK
- EYPT
- Stock Information
- Founded
- MNTK 1980
- EYPT 1987
- Country
- MNTK United States
- EYPT United States
- Employees
- MNTK N/A
- EYPT N/A
- Industry
- MNTK Natural Gas Distribution
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- MNTK Utilities
- EYPT Industrials
- Exchange
- MNTK Nasdaq
- EYPT Nasdaq
- Market Cap
- MNTK 269.2M
- EYPT 579.4M
- IPO Year
- MNTK 2021
- EYPT 2005
- Fundamental
- Price
- MNTK $2.71
- EYPT $10.15
- Analyst Decision
- MNTK Hold
- EYPT Strong Buy
- Analyst Count
- MNTK 3
- EYPT 8
- Target Price
- MNTK $3.33
- EYPT $24.75
- AVG Volume (30 Days)
- MNTK 221.6K
- EYPT 784.9K
- Earning Date
- MNTK 08-07-2025
- EYPT 08-06-2025
- Dividend Yield
- MNTK N/A
- EYPT N/A
- EPS Growth
- MNTK N/A
- EYPT N/A
- EPS
- MNTK 0.05
- EYPT N/A
- Revenue
- MNTK $179,552,000.00
- EYPT $56,042,000.00
- Revenue This Year
- MNTK $3.00
- EYPT N/A
- Revenue Next Year
- MNTK $13.24
- EYPT N/A
- P/E Ratio
- MNTK $52.03
- EYPT N/A
- Revenue Growth
- MNTK N/A
- EYPT 12.04
- 52 Week Low
- MNTK $1.68
- EYPT $3.91
- 52 Week High
- MNTK $6.13
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- MNTK 67.12
- EYPT 62.47
- Support Level
- MNTK $2.16
- EYPT $8.96
- Resistance Level
- MNTK $2.35
- EYPT $10.20
- Average True Range (ATR)
- MNTK 0.18
- EYPT 0.76
- MACD
- MNTK 0.05
- EYPT -0.03
- Stochastic Oscillator
- MNTK 91.67
- EYPT 62.90
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.